Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Two series of MEK/c-Src kinase inhibitors claimed by AstraZeneca

June 29, 2004

New antiangiogenic agents in early development at Bayer

June 28, 2004

New phase II study of talabostat in CLL

June 28, 2004

Positive interim results from phase II trial of FK-228 in CTCL and PTCL

June 28, 2004

Synthetic adrenal steroid hormones protect from chemotherapy or radiation-induced myelodepression

June 28, 2004

Merck & Co. and Vertex collaborate on development of VX-680

June 28, 2004

CuraGen and Seattle Genetics sign ADC technology agreement

June 28, 2004

Safety issues associated with Pivanex plus docetaxel in phase IIb study

June 28, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 25, 2004

Roche claims two series of protein kinase inhibitors for use in cancer therapy

June 25, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...